IL6R and neoplasm: Furthermore, the IL-6R-neutralizing antibody inhibited STAT3 activation induced by MpMDCS stimulation in SBC-3 cells (Fig. 5c), suggesting that MpMDCS also enhances tumor proliferation via STAT3 activation induced by the IL-6/IL-6R signaling pathway.